Insiders Akero Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 08/05/2024 am IST			5-day change	1st Jan Change
22.02 ^USD	-0.41%		+10.71%	-5.70%

30/04	Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer	CI
08/03	Akero Therapeutics Raises $367 Million From Share Offering	MT

Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer	30/04	CI
Akero Therapeutics Insider Sold Shares Worth $732,727, According to a Recent SEC Filing	07/03	MT
Akero Therapeutics Insider Sold Shares Worth $2,465,063, According to a Recent SEC Filing	07/03	MT
Akero Therapeutics Insider Bought Shares Worth $1,982,940, According to a Recent SEC Filing	12/12	MT
Akero Therapeutics Insider Sold Shares Worth $1,197,827, According to a Recent SEC Filing	05/23/05	MT
Akero Therapeutics Insider Sold Shares Worth $1,244,248, According to a Recent SEC Filing	19/23/19	MT
Insider Buy: Akero Therapeutics	11/23/11	MT
Insider Sell: Akero Therapeutics	04/23/04	MT
Insider Buy: Akero Therapeutics	02/23/02	MT
Insider Sell: Akero Therapeutics	07/23/07	MT
Insider Sell: Akero Therapeutics	26/23/26	MT
Insider Sell: Akero Therapeutics	22/23/22	MT
Insider Sell: Akero Therapeutics	22/23/22	MT
Insider Sell: Akero Therapeutics	22/23/22	MT
Insider Sell: Akero Therapeutics	06/23/06	MT
Insider Sell: Akero Therapeutics	04/23/04	MT
Insider Sell: Akero Therapeutics	04/23/04	MT
Insider Sell: Akero Therapeutics	04/23/04	MT
Insider Sell: Akero Therapeutics	19/23/19	MT
Akero Therapeutics, Inc. Announces the Appointment of Patrick Lamy as Senior Vice President, Commercial Strategy	10/23/10	CI

No results for this search